Physical Impairment and Function in Children and Adolescents With Sickle Cell Disease: A Systematic Review

Victoria Marchese1, Kelly Rock1, Andria Harpold1

  • 1Department of Physical Therapy and Rehabilitation Science, University of Maryland School of Medicine, Baltimore, MD.

Insights

Children and adolescents with sickle cell disease (SCD) experience significant physical impairments and functional limitations. These deficits impact muscle, bone, and overall physical performance, highlighting a critical need for targeted interventions.

Area of Science:

  • Pediatric Hematology
  • Rehabilitation Medicine
  • Clinical Research

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder affecting red blood cells.
  • Children and adolescents with SCD often face multifaceted health challenges beyond hematological aspects.
  • Understanding physical impairments is crucial for comprehensive care and improving quality of life.

Purpose of the Study:

  • To systematically review and synthesize evidence on physical impairments and physical function in pediatric SCD.
  • To identify the range and severity of physical deficits in this population.
  • To inform clinical practice and future research directions.

Main Methods:

  • A comprehensive systematic literature search was conducted across multiple databases (PubMed, Embase, CINAHL, Cochrane, Dissertations & Theses).
  • Inclusion criteria focused on SCD, physical impairments/function, and pediatric populations (1990-2020).
  • Rigorous screening and data extraction processes were employed by independent reviewers.

Main Results:

  • The review identified significant physical impairments and functional limitations in children and adolescents with SCD compared to controls.
  • Deficits were observed across various domains including muscle/bone composition (19%-58%), muscle strength, cardiopulmonary function, and motor performance.
  • Limitations also extended to physical activity levels and self-reported physical function in quality of life measures.

Conclusions:

  • Children and adolescents with SCD exhibit notable physical impairments and functional limitations.
  • There is a need for collaborative development of standardized methods to define and measure physical function in pediatric SCD.
  • Further research is warranted to understand the underlying factors contributing to these physical deficits.
Abstract

Related Concept Videos

The Functions of the Skeletal System01:22

The Functions of the Skeletal System

The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...
5.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
28
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35